Efficacy of compound Kushen injection plus radiotherapy on nonsmall-cell lungcancer: A systematic review and meta-Analysis

Journal of Cancer Research and Therapeutics

Volumn 12, Issue 4, 2016, Pages 1298-1306

  Wang, Shanshan ^a   Lian, Xiaobo ^a   Sun, Miaomiao ^a   Luo, Lei ^a   Guo, Lizhong ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Compound Kushen injection; meta Analysis; nonsmall cell lung cancer; radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CHINESE DRUG; KUSHEN; UNCLASSIFIED DRUG; HERBACEOUS AGENT;

ARTICLE; BONE MARROW SUPPRESSION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ESOPHAGITIS; HUMAN; META ANALYSIS; NON SMALL CELL LUNG CANCER; QUALITY OF LIFE; RADIATION PNEUMONIA; SYSTEMATIC REVIEW; ADVERSE EFFECTS; CARCINOMA, NON-SMALL-CELL LUNG; CHINESE MEDICINE; LUNG NEOPLASMS; MULTIMODALITY CANCER THERAPY; PROCEDURES; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DRUGS, CHINESE HERBAL; HUMANS; LUNG NEOPLASMS; MEDICINE, CHINESE TRADITIONAL; QUALITY OF LIFE; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 85012225097     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.199538     Document Type: Article

References (37)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in Globocan 2012. Int J Cancer 2015;136:E359-86.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2015;65:5-29.
3. She J, Yang P, Hong Q, Bai C. Lung cancer in China: Challenges and interventions. Chest 2013;143:1117-26.
4. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, et al. Non-small cell lung cancer. J Natl Compr Canc Netw 2012;10:1236-71.
5. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer 2003;41:245-58.
6. Spiro SG, Gould MK, Colice GL; American College of Chest Physicians. Initial evaluation of the patient with lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007;132 3 Suppl: 149S-60S.
7. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al., editors. Seer Cancer Statistics Review, 1975-2012. Bethesda, MD, USA: National Cancer Institute; 2015.
8. Dilling TJ. Radiation dose in non-small cell lung cancer: Too much of a good thing? Int J Radiat Oncol Biol Phys 2014;90:979-82.
9. Yamashita H, Takahashi W, Haga A, Nakagawa K. Radiation pneumonitis after stereotactic radiation therapy for lung cancer. World J Radiol 2014;6:708-15.
10. Parashar B, Arora S, Wernicke AG. Radiation therapy for early stage lung cancer. Semin Intervent Radiol 2013;30:185-90.
11. Yilmaz S, Adas YG, Hicsonmez A, Andrieu MN, Akyurek S, Gokce SC. Evaluation of the radiation pneumonia development risk in lung cancer cases. Asian Pac J Cancer Prev 2014;15:7371-5.
12. Sun FG, Sun XY. Sophora flavescens. In: Shen Nong Ben Cao Jing. Beijing: Scientific and Technical Documents Publishing House; 1999. p. 59.
13. Tian J, Wang WH, Gao HM, Wang ZM. Determination of matrine, sophoridine and oxymatrine in compound Kushen injection by HPLC. Zhongguo Zhong Yao Za Zhi 2007;32:222-4.
14. Qi L, Zhang J, Zhang Z. Determination of four alkaloids in compound Kushen injection by high performance liquid chromatography with ionic liquid as mobile phase additive. Se Pu 2013;31:249-53.
15. Sun M, Cao H, Sun L, Dong S, Bian Y, Han J, et al. Antitumor activities of Kushen: Literature review. Evid Based Complement Alternat Med 2012;2012:373219.
16. Xu W, Lin H, Zhang Y, Chen X, Hua B, Hou W, et al. Compound Kushen injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/ß-catenin pathway. J Exp Clin Cancer Res 2011;30:103.
17. Zhou SK, Zhang RL, Xu YF, Bi TN. Antioxidant and immunity activities of fufang Kushen injection liquid. Molecules 2012;17:6481-90.
18. Shao Q. The recent effect of radiotherapy combined with compound Kushen injection for esophageal cancer. Radiother Oncol 2011;99:S372-3.
19. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Ver. 5.1.0. England: The Cochrane Collaboration; 2011. Available from: www.cochrane-handbook.org.
20. The World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization; 1979.
21. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980;45:2220-4.
22. Review Manager (RevMan) [Computer Program]. Ver. 5.3. Copenhagen: The Nordic Cochrane Centre, the Cochrane Collaboration; 2014.
23. Wei H. Multi-center, randomized controlled clinical study of radiation pneumonitis treated with compound Kushen injection in primary lung cancer patients. Chin J New Drugs 2013;22:2065-8.
24. Ran L. Clinical observation of compound Kushen injection combined with radiotherapy for treatment of 50 cases of lung cancer. Forum Tradit Chin Med 2015;30:2015.
25. Xianghui L. Clinical efficacy and safety of compound Kushen injection in the treatment of lung injury after radiotherapy. Prog Mod Biomed 2015;15:3096-8.
26. Dongjiang S. Study on the prevention and treatment of radiation pneumonia in the primary lung cancer with compound Kushen injection. Pract J Cancer 2014;29:460-2.
27. Wanning T. Observation on the efficacy of compound Kushen injection combined with gamma knife in the treatment of advanced non small cell lung cancer. Chin J Inf Tradit Chin Med 2011;18:83-4.
28. Shengye W. Compound Kushen injection combined with radiotherapy for locally advanced non small cell lung cancer. Chin J New Drugs 2012;21:540-2.
29. Qingshan Y. Observation on the efficacy of compound Kushen injection in the prevention of radiation-induced lung injury. China Pharm 2011;22:360-1.
30. Qinghuai Z. Observation on the effect of compound Kushen injection in the treatment of non small cell lung cancer. Chin J Mod Drug Appl 2008;22:68-9.
31. Zhongren Z. Clinical observation of compound matrine injection combined with radiotherapy in the treatment of advanced non-small cell lung cancer. Tianjin Pharm 2013;25:51-2.
32. Wen Z. The application of combined Yanshu injection with radiation therapy in the treatment of elderly patients with non small cell lung cancer. Chinese J Gerontol 2010;30:3800-1.
33. Haisheng Z. Effect of compound Kushen injection combined with radiotherapy in the treatment of elderly patients with advanced non-small cell lung cancer. Shanxi J Tradit Chin Med 2011;27:23-5.
34. Zhanwen G. The effect on the immune function of lung cancer patients treated with combined Yanshu injection and radiotherapy. Clin Med Chin 2002;18:451-2.
35. Wenjing D, Baozhen Z, Guochao W, Xia H, Jie L. Clinical research of alleviating radiation-induced lung injury and improving the quality of life by compound Kushen injection. Cancer Res Clin 2013;25:612-4.
36. Ernst E, Lee MS. A trial design that generates only positive results. J Postgrad Med 2008;54:214-6.
37. Schulz KF, Altman DG, Moher D; Consort Group. Consort 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010;63:834-40.